A high incidence of positive results is obtained with in vitro genotoxicity tests, which do not correlate with the in vivo negative results in many cases. To address this issue, the metabolic profile of rat liver 9000 × g supernatant fraction (S9) pretreated with phenobarbital (PB) and 5,6-benzoflavone (BNF) was characterized. Furthermore, the in vitro micronucleus tests of 10 compounds were performed with PB-BNF-induced rat S9. PB-BNF increased cytochrome P450 (CYP) activity and CYP1A1, CYP1A2, CYP2B1/2, CYP2C6, CYP3A1, and CYP3A2 expression in rat S9, whereas it decreased CYP2C11 and CYP2E1 expression. PB-BNF-induced S9 enhanced the micronucleus induction (MI) of benzo[a]pyrene (BaP), cyclophosphamide (CPA), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine hydrochloride (PhIP), which are metabolized by CYP1A1, CYP2C6, and CYP1A2, respectively. In contrast, coumarin and chlorpheniramine showed MI with PB-BNF-induced S9 despite the fact that they show negative results in the in vivo studies. Furthermore, diclofenac, piroxicam, lansoprazole, and caffeine showed MI regardless of the enzyme induction by PB-BNF, whereas phenacetin did not show MI. These results indicate that PB-BNF-induced rat S9 is effective in detecting the genotoxic potential of promutagens, such as BaP, CPA, and PhIP, but not of coumarin and chlorpheniramine, probably due to the differences in the in vitro and in vivo metabolic profile and its exposure levels of the drugs.
"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410845713056263296","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000400162959"}],"foaf:name":[{"@language":"en","@value":"Kishino Yuki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}]},{"@id":"https://cir.nii.ac.jp/crid/1410845713056263301","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000400162960"}],"foaf:name":[{"@language":"en","@value":"Hasegawa Tomoko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}]},{"@id":"https://cir.nii.ac.jp/crid/1410845713056263297","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000400162961"}],"foaf:name":[{"@language":"en","@value":"Arakawa Shingo"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}]},{"@id":"https://cir.nii.ac.jp/crid/1410845713056263298","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000400162962"}],"foaf:name":[{"@language":"en","@value":"Shibaya Yukari"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}]},{"@id":"https://cir.nii.ac.jp/crid/1410845713056263299","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000400162963"}],"foaf:name":[{"@language":"en","@value":"Yamoto Takashi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}]},{"@id":"https://cir.nii.ac.jp/crid/1410845713056263300","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000400162964"}],"foaf:name":[{"@language":"en","@value":"Mori Kazuhiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03881350"},{"@type":"LISSN","@value":"03881350"},{"@type":"EISSN","@value":"18803989"},{"@type":"NDL_BIB_ID","@value":"029658342"},{"@type":"ISSN","@value":"03881350"},{"@type":"NCID","@value":"AN00002808"}],"prism:publicationName":[{"@language":"en","@value":"The Journal of Toxicological Sciences"},{"@language":"ja","@value":"Ｔｈｅ Ｊｏｕｒｎａｌ ｏｆ Ｔｏｘｉｃｏｌｏｇｉｃａｌ Ｓｃｉｅｎｃｅｓ"},{"@language":"en","@value":"J. Toxicol. Sci."}],"dc:publisher":[{"@language":"en","@value":"The Japanese Society of Toxicology"},{"@language":"ja","@value":"一般社団法人 日本毒性学会"}],"prism:publicationDate":"2019","prism:volume":"44","prism:number":"3","prism:startingPage":"145","prism:endingPage":"153"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"http://id.ndl.go.jp/bib/029707480"},{"@id":"https://ndlsearch.ndl.go.jp/books/R000000004-I029707480"},{"@id":"https://www.jstage.jst.go.jp/article/jts/44/3/44_145/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2020013400"}],"availableAt":"2019","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=%3Ci%3EIn%20vitro%3C/i%3E%20micronucleus%20test","dc:title":"In vitro micronucleus test"},{"@id":"https://cir.nii.ac.jp/all?q=Metabolic%20activation%20system","dc:title":"Metabolic activation system"},{"@id":"https://cir.nii.ac.jp/all?q=Cytochrome%20P450%20enzyme","dc:title":"Cytochrome P450 enzyme"},{"@id":"https://cir.nii.ac.jp/all?q=Inducers","dc:title":"Inducers"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011145860478336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Assay of phenacetin genotoxicity using in vitro and in vivo test systems"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621518127616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Carcinogenicity of analgesics: Long‐term treatment of sprague‐dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095362605312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Chromosomal aberration tests on 29 chemicals combined with S9 mix in vitro"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095842852736","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lack of effect of coumarin on the formation of micronuclei in an in vivo mouse micronucleus assay"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570103381632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Metabolic Detoxification Determines Species Differences in Coumarin-Induced Hepatotoxicity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570584987264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Lack of effect of coumarin on unscheduled DNA synthesis in the in vivo rat hepatocyte DNA repair assay"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571048187904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A four-day oral treatment regimen for simultaneous micronucleus analyses in the glandular stomach, colon, and bone marrow of rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044794282368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046231414016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520353790208","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995587163392","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468874609664","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"StereoselectiveN-Demethylation of Chlorpheniramine by Rat-liver Microsomes and the Involvement of Cytochrome P450 Isozymes"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469388281600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cytochromes P450, Drugs, and Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470873702784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or .beta.-naphthoflavone"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944622285312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945077057280","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Carcinogens are Mutagens: A Simple Test System Combining Liver Homogenates for Activation and Bacteria for Detection"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945618327424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946041204992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Strategy for genotoxicity testing—Metabolic considerations"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418354949504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics of chlorpheniramine"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418929621632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893975795456","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"An adaptation of the human HepaRG cells to the in vitro micronucleus assay"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895027984896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844916035200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845548252160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics."}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320024228352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Safety and pharmacokinetics of oral lansoprazole in preadolescent rats exposed from weaning through sexual maturity"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320619894400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Genotoxic effects of heterocyclic aromatic amines in human derived hepatoma (HepG2) cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320835000576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794948571136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"On the metabolizing systems for short-term genotoxicity assays: a review"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795801497472","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The micronucleus test with peripheral reticulocytes from phenacetin-treated mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269247019776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269531423616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The effect of caffeine in the in vivo SCE and micronucleus mutagenicity tests"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679263595904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Biotransformation of coumarin derivatives (2). Oxidative metabolism of 7-alkoxycoumarin by microsomal enzymes and a simple assay procedure for 7-alkoxycoumarin O-dealkylase."},{"@value":"Biotransformation of Coumarin Derivatives-2-Oxidative Metabolism of 7-Alkoxycoumarin by Microsomal Enzymes and а Simple Assay Procedure for 7-Alkoxycoumarin 0-Dealkylase"},{"@language":"ja-Kana","@value":"Biotransformation of Coumarin Derivativ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282752342509824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Species differences in micronucleus induction of the clastogenic compounds associated with drug metabolic profile"}]},{"@id":"https://cir.nii.ac.jp/crid/1390849376476862976","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Construction of a PPARα Reporter Assay System with Drug-Metabolizing Capability"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892082713216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Correlation between the results of in vitro and in vivo chromosomal damage tests in consideration of exposure levels of test chemicals"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2007115848"},{"@type":"NDL_SEARCH","@value":"oai:ndlsearch.ndl.go.jp:R000000004-I029707480"},{"@type":"CROSSREF","@value":"10.2131/jts.44.145"},{"@type":"PUBMED","@value":"30842367"},{"@type":"CIA","@value":"130007610478"},{"@type":"OPENAIRE","@value":"doi_dedup___::c4d686488b5cbfc9d0e0517a8b0897a4"},{"@type":"CROSSREF","@value":"10.2131/jts.44.701_references_DOI_5ZCvVZ5scK4RoQBMgNNzfF23rqX"},{"@type":"CROSSREF","@value":"10.1248/bpbreports.3.1_7_references_DOI_5ZCvVZ5scK4RoQBMgNNzfF23rqX"}]}